Kinase Inhibitor Sorafenib Modulates Immunosuppressive Cell Populations in a Murine Liver Cancer Model

Laboratory Investigation - United Kingdom
doi 10.1038/labinvest.2010.205
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Hematein, a Casein Kinase II Inhibitor, Inhibits Lung Cancer Tumor Growth in a Murine Xenograft Model

International Journal of Oncology
Cancer ResearchOncology
2013English

Stimulatory Effects of the Multi-Kinase Inhibitor Sorafenib on Human Bladder Cancer Cells

British Journal of Pharmacology
Pharmacology
2010English

Mesenchymal Stem Cell Therapy Modulates Synovial Macrophages in a Murine Model of Osteoarthritis

Osteoarthritis and Cartilage
Sports MedicineRheumatologyOrthopedicsBiomedical Engineering
2019English

Correction: Synergistic Interaction Between the HDAC Inhibitor, MPT0E028, and Sorafenib in Liver Cancer CellsIn VitroandIn Vivo

Clinical Cancer Research
Cancer ResearchOncology
2018English

Visualizing Cancer Cell Dynamics in a Liver Slice Model

Microscopy and Microanalysis
Instrumentation
2011English

Myricetin Modulates Macrophage Polarization and Mitigates Liver Inflammation and Fibrosis in a Murine Model of Nonalcoholic Steatohepatitis

Frontiers in Medicine
Medicine
2020English

Pan-Tam Tyrosine Kinase Inhibitor BMS-777607 Enhances Anti-Pd-1 mAb Efficacy in a Murine Model of Triple-Negative Breast Cancer

Cancer Research
Cancer ResearchOncology
2019English

Increased Intratumoral Fluorothymidine Uptake Levels Following Multikinase Inhibitor Sorafenib Treatment in a Human Renal Cell Carcinoma Xenograft Model

Oncology Letters
Cancer ResearchOncology
2013English

Immunosuppressive Effect of B7-H4 Pathway in a Murine Systemic Lupus Erythematosus Model

Frontiers in Immunology
AllergyImmunology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy